Skip to main

Xu Liu, PhD, MS

${headerImageAssetTitle}

Biography

Xu Liu, PhD, MS, is an assistant professor in the Department of Biochemistry at Emory University School of Medicine. Dr. Liu is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute.

Education

Dr. Liu received his MS in biochemistry from Beijing Normal University in China. He earned his PhD from University of Iowa in Iowa City, Iowa. He completed his postdoctoral training at Emory University School of Medicine in Atlanta, Georgia, primarily in the laboratory of Eric Ortlund, PhD.

Titles & Roles

  • Assistant Professor, Department of Biochemistry
    Emory University School of Medicine

Research

With a background in biochemistry, biophysics and structural biology, Dr. Liu's long-standing research interest is to study protein-ligand (drug) interactions to improve medical treatment to human illness. Dr. Liu explored the structure, dynamics and thermodynamic origins of distinct specificities of PDZ-ligand interactions during his PhD studies with support by an American Heart Association predoctoral fellowship.

Publications

Title/Journal Authors Publication Date

The Brain Tumor Segmentation - Metastases (BraTS-METS) Challenge 2023: Brain Metastasis Segmentation on Pre-treatment MRI.

ArXiv

 AW Moawad, A Janas, U Baid, D Ramakrishnan, R Saluja, N Ashraf, N Maleki, L Jekel, N Yordanov, P Fehringer, A Gkampenis, R Amiruddin, A Manteghinejad, M Adewole, J Albrecht, U Anazodo, S Aneja, SM Anwar, T Bergquist, V Chiang, V Chung, GM Conte, F Dako, J Eddy, I Ezhov, N Khalili, K Farahani, JE Iglesias, Z Jiang, E Johanson, AF Kazerooni, F Kofler, K Krantchev, D LaBella, K Van Leemput, HB Li, MG Linguraru, X Liu, Z Meier, BH Menze, H Moy, K Osenberg, M Piraud, Z Reitman, RT Shinohara, C Wang, B Wiestler, W Wiggins, U Shafique, K Willms, A Avesta, K Bousabarah, S Chakrabarty, N Gennaro, W Holler, M Kaur, P LaMontagne, M Lin, J Lost, DS Marcus, R Maresca, S Merkaj, G Cassinelli Pedersen, M von Reppert, A Sotiras, O Teytelboym, N Tillmans, M Westerhoff, A Youssef, D Godfrey, S Floyd, A Rauschecker, J Villanueva-Meyer, I Pflüger, J Cho, M Bendszus, G Brugnara, J Cramer, GJG Perez-Carillo, DR Johnson, A Kam, BYM Kwan, L Lai, NU Lall, F Memon, M Krycia, SN Patro, B Petrovic, TY So, G Thompson, L Wu, EB Schrickel, A Bansal, F Barkhof, C Besada, S Chu, J Druzgal, A Dusoi, L Farage, F Feltrin, A Fong, SH Fung, RI Gray, I Ikuta, M Iv, AA Postma, A Mahajan, D Joyner, C Krumpelman, L Letourneau-Guillon, CM Lincoln, ME Maros, E Miller, FEA Morón, EA Nimchinsky, O Ozsarlak, U Patel, S Rohatgi, A Saha, A Sayah, ED Schwartz, R Shih, MS Shiroishi, JE Small, M Tanwar, J Valerie, BD Weinberg, ML White, R Young, VM Zohrabian, A Azizova, MMT Brüßeler, M Ghonim, M Ghonim, A Okar, L Pasquini, Y Sharifi, G Singh, N Sollmann, T Soumala, M Taherzadeh, P Vollmuth, M Foltyn-Dumitru, A Malhotra, AH Abayazeed, F Dellepiane, P Lohmann, VM Pérez-García, H Elhalawani, MC de Verdier, S Al-Rubaiey, RD Armindo, K Ashraf, MM Asla, M Badawy, J Bisschop, NB Lomer, J Bukatz, J Chen, P Cimflova, F Corr, A Crawley, L Deptula, T Elakhdar, IH Shawali, S Faghani, A Frick, V Gulati, MA Haider, F Hierro, RH Dahl, SM Jacobs, KJ Hsieh, SG Kandemirli, K Kersting, L Kida, S Kollia, I Koukoulithras, X Li, A Abouelatta, A Mansour, RC Maria-Zamfirescu, M Marsiglia, YS Mateo-Camacho, M McArthur, O McDonnell, M McHugh, M Moassefi, SM Morsi, A Munteanu, KK Nandolia, SR Naqvi, Y Nikanpour, M Alnoury, AMA Nouh, F Pappafava, MD Patel, S Petrucci, E Rawie, S Raymond, B Roohani, S Sabouhi, LM Sanchez-Garcia, Z Shaked, PP Suthar, T Altes, E Isufi, Y Dhemesh, J Gass, J Thacker, AR Tarabishy, B Turner, S Vacca, GK Vilanilam, D Warren, D Weiss, F Worede, S Yousry, W Lerebo, A Aristizabal, A Karargyris, H Kassem, S Pati, M Sheller, KEE Link, E Calabrese, NH Tahon, A Nada, YS Velichko, S Bakas, JD Rudie, M Aboian 12/09/2024

Activity and phosphatidylcholine transfer protein interactions of skeletal muscle thioesterase Them2 enable hepatic steatosis and insulin resistance.

The Journal of biological chemistry

 Y Xie, X Liu, W Liu, LR Carr, LP Lee, N Imai, EA Ortlund, DE Cohen 11/01/2024

Human gut microbes express functionally distinct endoglycosidases to metabolize the same N-glycan substrate.

Nature communications

 DE Sastre, N Sultana, M V A S Navarro, M Huliciak, J Du, JO Cifuente, M Flowers, X Liu, P Lollar, B Trastoy, ME Guerin, EJ Sundberg 06/15/2024

Machine Learning-Based Prediction of Pediatric Ulcerative Colitis Treatment Response Using Diagnostic Histopathology.

Gastroenterology

 X Liu, S Prasath, I Siddiqui, TD Walters, LA Denson, J Dhaliwal 05/01/2024

Evolution of androgen receptors contributes to species variation in androgenic regulation of communication signals in electric fishes.

Molecular and cellular endocrinology

 MR Proffitt, X Liu, EA Ortlund, GT Smith 12/01/2023

High-throughput screening identifies small molecule inhibitors of thioesterase superfamily member 1: Implications for the management of non-alcoholic fatty liver disease.

Molecular metabolism

 CS Krumm, RS Landzberg, L Ramos-Espiritu, C Adura, X Liu, M Acuna, Y Xie, X Xu, MC Tillman, Y Li, JF Glickman, EA Ortlund, JD Ginn, DE Cohen 12/01/2023

DNA-PK is activated by SIRT2 deacetylation to promote DNA double-strand break repair by non-homologous end joining.

Nucleic acids research

 PE Head, P Kapoor-Vazirani, GP Nagaraju, H Zhang, SK Rath, NC Luong, R Haji-Seyed-Javadi, F Sesay, SY Wang, DM Duong, W Daddacha, EV Minten, B Song, D Danelia, X Liu, S Li, EA Ortlund, NT Seyfried, DM Smalley, Y Wang, X Deng, WS Dynan, B El-Rayes, AJ Davis, DS Yu 08/25/2023

Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment.

Future oncology (London, England)

 N Turner, C Huang-Bartlett, K Kalinsky, M Cristofanilli, G Bianchini, S Chia, H Iwata, W Janni, CX Ma, EL Mayer, YH Park, S Fox, X Liu, S McClain, FC Bidard 03/01/2023